Abryl Laboratories, a CDMO based in India, specializes in sterile fill/finish services. Established in 2017, the company focuses on providing high-quality solutions for pharmaceutical and biotechnology clients worldwide. Abryl's state-of-the-art facilities are designed to meet stringent global regulatory standards, allowing them to deliver end-to-end development and manufacturing services. The company is capable of handling a range of sterile formulations, including injectables and lyophilized products.